MedPath

In-stent Restenosis and Pericoronary Fat Attenuation Index

Completed
Conditions
In-stent Restenosis
Registration Number
NCT05512832
Lead Sponsor
RenJi Hospital
Brief Summary

This study aims to investigate the predictive value of fat attenuation index (FAI) and related radiomics characteristics of pericoronary fat in patients after percutaneous coronary intervention (PCI) for the occurrence of in-stent restenosis (ISR) during the follow-up period (9 to 24 months). The results of this study are expected to provide an early assessment of the inflammation around the coronary lesion segment in patients after PCI, and provide a basis for early targeted intensive drug therapy in clinical practice.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
126
Inclusion Criteria
  • Patients with coronary heart disease who have undergone PCI;
  • Patients followed up coronary angiography 9 to 24 months after PCI;
  • Patients received chest CT examination during inpatient/outpatient follow-up;
Exclusion Criteria
  • Patients with diseases of the immune system;
  • Patients with history of tumor diseases;
  • Patients with chronic/acute infectious diseases;
  • Image quality is not sufficient for analysis;

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fat attenuation index (FAI)2022.8.15-2023.8.14

The pericoronary FAI was defined as the mean CT attenuation of the pericoronary adipose tissue (-190 to -30 HU). Peri-stent FAI was measured around the stent segment of all 3 major epicardial coronary vessels.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cardiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath